logo

For the Inventor, By the Inventor

St. Albans, United Kingdom

Iain C A F Robinson

This inventor holds 21 USPTO granted patents, primarily in Biotechnology. Top assignees: Genentech, Inc., Other. Active years: 2001-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iain C A F Robinson. Retrieved from https://idiyas.com/inventor/iain-c-a-f-robinson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 85.7

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2002)
  • St. Albans, GB (2001 - 2012)

Company Filing History:

goldMedal20 out of 3,300 
 
Genentech, Inc.
 patents
silverMedal1 out of 834,570 
Other
 patents

Years Active: 2001-2012

Loading Chart...
Areas of Expertise:
Cartilage Disorders
Insulin-like Growth Factor
Agonist Molecules
Therapeutics
Biopharmaceuticals
Molecular Biology
Protein Engineering
Drug Development
Tissue Regeneration
Gene Therapy
Pharmaceutical Composition
Biological Activity
21 patents (USPTO):Explore Patents
1. 8110548 - Method for treating cartilage disorders (2012-02-07),
2. 7947650 - Article of manufacture (2011-05-24),
3. 7423017 - Method for treating cartilage disorders (2008-09-09),
4. 6949349 - Insulin-like growth factor agonist molecules (2005-09-27),
5. 6750321 - Insulin-like growth factor agonist molecules (2004-06-15),
6. 6743894 - Insulin-like growth factor agonist molecules (2004-06-01),
7. 6716586 - Insulin-like growth factor agonist molecules (2004-04-06),
8. 6713451 - Insulin-like growth factor agonist molecules (2004-03-30),
9. 6693079 - Insulin-like growth factor agonist molecules (2004-02-17),
10. 6693078 - Insulin-like growth factor agonist molecules (2004-02-17),
11. 6689751 - Insulin-like growth factor agonist molecules (2004-02-10),
12. 6683053 - Insulin-like growth factor agonist molecules (2004-01-27),
13. 6680298 - Insulin-like growth factor agonist molecules (2004-01-20),
14. 6677305 - Insulin-like growth factor agonist molecules (2004-01-13),
15. 6645775 - Insulin-like growth factor agonist molecules (2003-11-11),

Innovative Contributions of Iain C A F Robinson in Cartilage Disorders

Introduction

Iain C A F Robinson, based in St. Albans, Great Britain, is a prominent inventor recognized for his significant contributions to the field of cartilage treatment. With an impressive portfolio of 21 patents, Robinson has been at the forefront of innovation, particularly in developing methods that address cartilage disorders.

Latest Patents

Among Robinson's latest patents is a groundbreaking method for treating cartilage disorders. This invention focuses on addressing cartilage that has been damaged by injury or degenerative conditions. The method involves using an IGF-1 analog with altered affinity for IGF-binding proteins (IGFBPs) or an IGFBP displacer peptide. This innovative approach prevents the interaction of IGF with an IGFBP without binding to a human IGF receptor, thereby offering potential pathways for effective treatment.

Career Highlights

Throughout his career, Iain C A F Robinson has contributed his expertise to notable companies such as Genentech, Inc. His work in research and development has not only advanced the understanding of cartilage disorders but also paved the way for novel therapeutic applications. His dedication to improving patient outcomes is evident through his innovative patents.

Collaborations

Robinson's journey has been marked by collaboration with esteemed professionals in the field, including coworkers Ross Graham Clark and Henry Bernard Lowman. These partnerships have fostered a rich exchange of ideas and have played a crucial role in the success of his inventions.

Conclusion

Iain C A F Robinson stands out as a leading inventor with a dedication to addressing challenging medical conditions through innovative solutions. His latest patents reflect a commitment to improving treatments for cartilage disorders, highlighting his significant impact on the field of biomedical research. With each invention, Robinson continues to push the boundaries of what is possible in medical innovation, solidifying his reputation as a valuable contributor to the advancement of healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…